Herbal hepatotoxicity: Analysis of cases with initially reported positive re-exposure tests

Digestive and Liver Disease

Volumn 46, Issue 3, 2014, Pages 264-269

  Teschke, Rolf ^a   Genthner, Alexander ^a   Wolff, Albrecht ^b   Frenzel, Christian ^c   Schulze, Johannes ^d   Eickhoff, Axel ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

Herb induced liver injury; Herbal hepatotoxicity; Herbs; Positive re exposure tests

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; CHAPARRAL EXTRACT; CHELIDONIUM EXTRACT; CIMICIFUGA RACEMOSA EXTRACT; EPHEDRA SINICA EXTRACT; FALLOPIA MULTIFLORA EXTRACT; GREEN TEA EXTRACT; HERBACEOUS AGENT; JIN BU HUAN; KAVA; KAVA EXTRACT; SENNA EXTRACT; UNCLASSIFIED DRUG; VISCUM ALBUM EXTRACT; XIAO CHAI HU TANG;

ACTAEA RACEMOSA; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOE; ARTICLE; CHELIDONIUM; CHINESE HERB; DRUG INDUCED DISEASE; DRUG REEXPOSURE; EPHEDRA SINICA; FALLOPIA MULTIFLORA; GERMANDER; HUMAN; LIVER INJURY; LIVER TOXICITY; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; REFERENCE DATABASE; SENNA; SYSTEMATIC REVIEW; TEA; VALIDITY; VISCUM ALBUM;

HERB INDUCED LIVER INJURY; HERBAL HEPATOTOXICITY; HERBS; POSITIVE RE-EXPOSURE TESTS;

ALANINE TRANSAMINASE; ALOE; BUPLEURUM; CAMELLIA SINENSIS; CHELIDONIUM; DRUG-INDUCED LIVER INJURY; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; KAVA; MALE; MISTLETOE; PLANTS, MEDICINAL; POLYGONUM; REPRODUCIBILITY OF RESULTS; SENNA PLANT; TEUCRIUM;

EID: 84893717527     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2013.10.020     Document Type: Article

References (75)

1. Bunchorntavakul C., Reddy K.R. Review article: herbal and dietary supplement hepatotoxicity. Alimentary Pharmacology & Therapeutics 2013, 37:3-17.
2. Teschke R., Wolff A., Frenzel C., et al. Herbal hepatotoxicity: a tabular compilation of reported cases. Liver International 2012, 32:1543-1556.
3. Kaplowitz N., DeLeve L.D. Drug-induced liver disease 2013, Academic Press, Waltham, MA, USA. 3rd ed.
4. Aithal G.P., Watkins P.B., Andrade R.J., et al. Case definition and phenotype standardization in drug-induced liver injury. Clinical Pharmacology & Therapeutics 2011, 89:806-815.
5. Chalasani N., Björnsson E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology 2010, 138:2246-2259.
6. National Institutes of Health (NIH) NIH launches free database of drugs associated with liver injury, October 12, News Release 2012, Available at: http://www.nih.gov/news/health/oct2012/niddk-12.htm [accessed 08.07.13].
7. National Institutes of Health (NIH), LiverTox: drug record Herbals and dietary supplements 2013, Last updated 20.02.12. Available at: http://www.livertox.nih.gov/Herbals_and_Dietary_Supplements.htm [accessed 08.07.13].
8. Teschke R., Frenzel C., Schulze J., Eickhoff A. Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods. World Journal of Gastroenterology 2013, 21:2864-2882.
9. García-Cortés M., Stephens C., Lucena M.I., et al. Causality assessment methods in drug induced liver injury: strengths and weaknesses. Journal of Hepatology 2011, 55:683-691.
10. Teschke R., Schulze J., Schwarzenboeck A., et al. Herbalife hepatotoxicity: evaluation of cases with positive re-exposure tests. World Journal of Hepatology 2013, 5:353-363.
11. Yang H.N., Kim D.J., Kim Y.M., et al. Aloe-induced toxic hepatitis. Journal of Korean Medical Science 2010, 25:492-495.
12. Teschke R., Schmidt-Taenzer W., Wolff A. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver unspecific Naranjo scale precise enough to ascertain causality. Pharmacoepidemiology and Drug Safety 2011, 20:567-582.
13. Batchelor W.B., Heathcote J., Wanless I.R. Chaparral-induced hepatic injury. American Journal of Gastroenterology 1995, 90:831-833.
14. Perharic-Walton L., Murray V. Toxicity of traditional Chinese herbal remedies. Lancet 1992, 340:674.
15. Kane J.A., Kane S.P., Jain S. Hepatitis induced by traditional Chinese herbs; possible toxic components. Gut 1995, 36:146-147.
16. Davies E.G., Pollock I., Steel H.M. Chinese herbs for eczema. Lancet 1990, 336:117.
17. Woolf G.M., Petrovic L.M., Rojter S.E., et al. Acute hepatitis associated with the Chinese herbal product Jin Bu Huan. Annals of Internal Medicine 1994, 121:729-735.
18. Horowitz R.S., Feldhaus K., Dart R.C., et al. The clinical spectrum of Jin Bu Huang toxicity. Archives of Internal Medicine 1996, 156:899-903.
19. Nadir A., Agrawal S., King P.D., Marshall J.B. Acute hepatitis associated with the use of a Chinese herbal product, Ma-huang. American Journal of Gastroenterology 1996, 91:1436-1438.
20. Itoh S., Marutani K., Nishijima T., et al. Liver injuries induced by herbal medicine, Syo-saiko-to (xiao- chai-hu-tang). Digestive Diseases and Sciences 1995, 40:1845-1848.
21. Larrey D., Vial T., Pauwels A., et al. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Annals of Internal Medicine 1992, 117:129-132.
22. Laliberté L., Villeneuve J.P. Hepatitis after the use of Germander, a herbal remedy. Canadian Medical Association Journal 1996, 154:1689-1692.
23. Strahl S., Ehret V., Dahm H.H., Maier K.P. Necrotising hepatitis after taking herbal remedies. Deutsche Medizinische Wochenschrift 1998, 123:1410-1414.
24. Benninger J., Schneider H.T., Schuppan D., et al. Acute hepatitis induced by Greater Celandine (Chelidonium majus). Gastroenterology 1999, 117:1234-1237.
25. Stickel F., Pöschl G., Seitz H.K., et al. Acute hepatitis induced by Greater Celandine (Chelidonium majus). Scandinavian Journal of Gastroenterology 2003, 38:565-568.
26. Peyrin-Biroulet L., Petitpain N., Kalt P., et al. Probable hepatotoxicity from epigallocatecol gallate used for phytotherapy. Gastroentérologie Clinique et Biologique 2004, 28:404-406.
27. Jimemez-Saenz M., Martinez-Sanchez M.delC. Acute hepatitis associated with the use of green tea infusions. Journal of Hepatology 2006, 44:616-617.
28. Bonkovsky H.L. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Annals of Internal Medicine 2006, 144:68-71. [Erratum in: Annals of Internal Medicine 2006;144:380].
29. García-Cortés M., Borraz Y., Lucena M.I., et al. Liver injury induced by natural remedies: an analysis of cases submitted to the Spanish Liver Toxicity Registry. Revista Española de Enfermedades Digestivas 2008, 100:688-695.
30. Sarma D.N., Barrett M.L., Chavez M.L., et al. Safety of green tea extract: a systematic review by the US Pharmacopeia. Drug Safety 2008, 31:469-484.
31. Harvey J., Colin-Jones D.G. Mistletoe hepatitis. British Medical Journal 1981, 282:186-187.
32. Jung K.A., Min H.J., Yoo S.S., et al. Drug-induced liver injury: twenty five cases of acute hepatitis following ingestion of Polygonum multiflorum Thun. Gut Liver 2011, 5:493-499.
33. Beuers U., Spengler U., Pape G.R. Hepatitis after chronic abuse of senna. Lancet 1991, 337:372-373.
34. Yang L., Aronsohn A., Hart J., Jensen D. Herbal hepatotoxicity from Chinese skullcap: a case report. World Journal of Hepatology 2012, 4:231-233.
35. Mahady G.B., Low Dog T., Barrett M.L., et al. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 2008, 15:628-638.
36. Mahady G., Dog T., Sarma N.D., et al. Letter to the editor. Pharmacoepidemiology and Drug Safety 2012, 21:339-340. [Erratum: 2012;21:787].
37. Teschke R., Schmidt-Taenzer W., Wolff A. USP suspected herbal hepatotoxicity: quality of causality assessment is more important than quantity of counted cases, not vice versa. Pharmacoepidemiology and Drug Safety 2012, 21:336-338. [Erratum: 2012;21:787].
38. Teschke R., Schulze J. Suspected herbal hepatotoxicity: requirements for appropriate causality assessment by the US Pharmacopeia. Drug Safety 2012, 35:1091-1097.
39. Teschke R., Schwarzenboeck A., Schmidt-Taenzer W., et al. Herb induced liver injury presumably caused by black cohosh: a survey of initially purported cases and herbal quality specifications. Annals of Hepatology 2011, 11:249-259.
40. Naser B., Schnitker J., Minkin M.J., et al. Hepatotoxicity suspected by black cohosh: no evidence by metaanalysis of randomized controlled clinical trials for isopropanolic black cohosh extract. Menopause 2011, 18:366-375.
41. Teschke R., Glass X., Schulze J., Eickhoff A. Suspected Greater Celandine hepatotoxicity: liver specific causality evaluation of published case reports from Europe. European Journal of Gastroenterology & Hepatology 2012, 24:270-280.
42. Teschke R., Frenzel C., Glass X., et al. Greater celandine hepatotoxicity: a clinical review. Annals of Hepatology 2012, 11:838-848.
43. Liss G., Lewis J.H. Drug-induced liver injury: what was new in 2008. Expert Opinion on Drug Metabolism & Toxicology 2009, 5:843-860.
44. Teschke R., Schwarzenboeck A., Hennermann K.H. Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. European Journal of Gastroenterology & Hepatology 2008, 20:1182-1193.
45. Teschke R. Kava hepatotoxicity - a clinical review. Annals of Hepatology 2010, 9:251-265.
46. Colin-Johnes D.G., Harvey J. Mistletoe hepatitis. British Medical Journal 1982, 284:744-745.
47. Farnsworth N.R., Loub W.D. Mistletoe hepatitis. British Medical Journal 1982, 283:1058.
48. National Institutes of Health (NIH) and LiverTox Roussel Uclaf Causality Assessment Method (RUCAM) in drug induced liver injury: manual of operations 2013, Available at:, [accessed 8 July]. http://www.livertox.nih.gov/rucam.html.
49. Teschke R., Schwarzenboeck A., Eickhoff A., et al. Clinical and causality assessment in herbal hepatotoxicity. Expert Opinion on Drug Safety 2013, 12:330-366.
50. Teschke R., Eickhoff A., Schulze J. Drug and herb induced liver injury in clinical and translational hepatology: causality assessment methods, quo vadis. Journal of Clinical and Translational Hepatology 2013, 1:59-74.
51. Danan G., Bénichou C. Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. Journal of Clinical Epidemiology 1993, 46:1323-1330.
52. Bénichou C., Danan G., Flahault A. Causality assessment of adverse reactions to drugs - II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. Journal of Clinical Epidemiology 1993, 46:1331-1336.
53. Danan G. Consensus meetings on: causality assessment of drug-induced liver injury. Journal of Hepatology 1988, 7:132-136.
54. Bénichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. Journal of Hepatology 1990, 11:272-276.
55. Bégaud B., Evreux J.C., Jouglard J., Lagier G. Unexpected or toxic drug reaction assessment (imputation). Actualization of the method used in France. Therapie 1985, 40:111-118.
56. Naranjo C.A., Busto U., Sellers E.M., et al. A method for estimating the probability of adverse drug reactions. Clinical Pharmacology & Therapeutics 1981, 30:239-245.
57. Andrade R.J., Camargo R., Lucena M.I., González-Grande R. Causality assessment in drug-induced hepatotoxicity. Expert Opinion on Drug Safety 2004, 3:329-344.
58. Andrade R.J., Robles M., Fernández-Castañer A., et al. Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists. World Journal of Gastroenterology 2007, 13:329-340.
59. WHO (World Health Organization) Assessments of the risk of hepatotoxicity with kava products 2007, WHO Document Production Services, Geneva, Switzerland.
60. Mazzanti G., Menniti-Ippolito F., Moro P.A., et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. European Journal of Clinical Pharmacology 2009, 65:331-341.
61. Rochon J., Protiva P., Seeff L.B., et al. Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury. Hepatology 2008, 48:1175-1183.
62. Björnsson E., Jacobsen E.I., Kalaitzakis E. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. Journal of Hepatology 2012, 56:374-380.
63. Björnsson E.S., Bergmann O.M., Björnsson H.K., et al. Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013, 144:1419-1425.
64. Andrade R.J., Lucena M.I., Fernández M.C., et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005, 129:512-521.
65. Larrey D., Faure S. Herbal medicine hepatotoxicity: a new step with development of specific biomarkers. Journal of Hepatology 2011, 54:599-601.
66. Teschke R., Schulze J., Schwarzenboeck A., et al. Herbal hepatotoxicity: suspected cases assessed for alternative causes. European Journal of Gastroenterology & Hepatology 2013, 10.1097/MEG.0b013e3283603e89.
67. Teschke R., Bahre R. Severe hepatotoxicity by Indian Ayurvedic herbal products: a structured causality assessment. Annals of Hepatology 2009, 8:258-266.
68. Chau T.N., Cheung W.I., Ngan T., the Hong Kong Herb-Induced Liver Injury Network (HK-HILIN), et al. Causality assessment of herb-induced liver injury using multidisciplinary approach and the Roussel Uclaf Causality assessment Method (RUCAM). Clinical Toxicology 2011, 49:34-39.
69. Teschke R. Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver International 2010, 30:1270-1279.
70. Teschke R., Lebot V. Proposal for a kava quality standardization code. Food and Chemical Toxicology 2011, 49:2503-2516.
71. Teschke R., Frenzel C., Glass X., et al. Herbal hepatotoxicity: a critical review. British Journal of Clinical Pharmacology 2013, 75:630-636.
72. Teschke R., Sarris J., Lebot V. Contaminant hepatotoxins as culprits for kava hepatotoxicity - fact or fiction. Phytotherapy Research 2013, 27:472-474.
73. Navarro V.J., Bonkovsky H.L., Hwang S.I., et al. Catechins in dietary supplements and hepatotoxicity. Digestive Diseases and Sciences 2013, 58:2682-2690.
74. Dalton H.R., Fellows H.J., Stableforth W., et al. The role of hepatitis E virus testing in drug-induced liver injury. Alimentary Pharmacology & Therapeutics 2007, 26:1429-1435.
75. Davern T.J., Chalasani N., Fontana R.J., for the Drug-Induced Liver Injury Network (DILIN), et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011, 141:1665-1672.